Searchable abstracts of presentations at key conferences in endocrinology

ea0081p82 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Irisin in pediatric patients with Prader Willi Syndrome: the role of body composition and glucose metabolism

Mai Stefania , Fintini Danilo , Mele Chiara , Convertino Alessio , Bocchini Sarah , Grugni Graziano , Aimaretti Gianluca , Vietti Roberta , Scacchi Massimo , Crino Antonino , Marzullo Paolo

Irisin is a myokine involved in the browning of white adipose tissue and in the regulation of energy expenditure, glucose tolerance and insulin sensitivity. It was previously demonstrated that obese adults with Prader-Willi syndrome (PWS) harbor lower irisin levels than individuals with common obesity. Significant associations seem to relate irisin to muscle mass, REE, insulin resistance and triglycerides and also the strongest independent predictors of irisin levels were PWS ...

ea0035p853 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Assessment of the hypothalamus–pituitary–adrenal axis with different corticotropin tests in adult patients with Prader–Willi syndrome

Grugni Graziano , Corrias Andrea , Sartorio Alessandro , Beccaria Luciano , Bocchini Sarah , Di Candia Stefania , Fintini Danilo , Iughetti Lorenzo , Mussa Alessandro , Ragusa Letizia , Gargantini Luigi , Salvatoni Alessandro , Delvecchio Maurizio , Chiumello Giuseppe , Crino Antonino

Introduction: Hypothalamic–pituitary anomalies are well proven in Prader–Willi syndrome (PWS). In this context, it has been previously reported that central adrenal insufficiency (CAI) may be part of the PWS phenotype. However, the diagnostics of CAI is critical and debated, due to the lack of fully reliable tests. Several studies have looked at the clinical usefulness of the low dose (1 μg) short Synacthen test (LDSST) compared to the conventional dose (250 &#9...